Search results
Advancements in Biologic Therapies for Psoriatic Arthritis
Medscape· 3 days agoThe latest developments in biological therapies for psoriatic arthritis (PsA) are reviewed by Dr...
6 Signs of an Autoimmune Disease That Can Be Easy to Miss
Self via Yahoo News· 7 days agoA few other notable autoimmune conditions that can cause joint issues? Lupus (one type that attacks...
Low stress resilience is linked to increased risk of psoriasis
Medical Xpress· 3 days agoAs part of the enlistment process, all the men underwent psychological assessment in accordance with...
Nail Psoriasis
Health via Yahoo News· 7 days agoWhat Causes Nail Psoriasis? Most people with nail psoriasis have psoriatic inflammation, such as plaque psoriasis (skin cells multiply more rapidly and...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 3 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said ...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 3 days ago-inhibiting monoclonal antibody. It was first approved as a treatment for moderate to severe plaque...
What To Know and Do About Arthritis Pain
Health via Yahoo News· 6 days agoArthritis is a condition that causes pain, stiffness, and inflammation in your joints. Fortunately, medications and home remedies can help relieve pain.
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 1 day agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
The Parsons Sun· 7 days ago- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)
Allegheny Financial Group LTD Increases Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoAllegheny Financial Group LTD boosted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 2.3% during the fourth quarter, according to the company in its most recent Form ...